Desipramine inhibits the growth of a mouse skin squamous cell carcinoma cell line and affects glucocorticoid receptor-mediated transcription

Molecular Carcinogenesis

Volumn 48, Issue 12, 2009, Pages 1123-1130

  Kinjo, Tatsuya ^a,b   Kowalczyk, Piotr ^a   Kowalczyk, Magdalena ^a   Walaszek, Zbigniew ^a   Nishimaki, Tadashi ^b   Slaga, Thomas J ^a   Hanausek, Margaret ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Fluocinolone acetonide; Glucocorticoid response element; Glucocorticoids; Metallothionein 1; SENCAR mice

Indexed keywords

DESIPRAMINE; FLUOCINOLONE ACETONIDE; GLUCOCORTICOID RECEPTOR; LUCIFERASE; METALLOTHIONEIN I; ANTIINFLAMMATORY AGENT; MESSENGER RNA; METALLOTHIONEIN; METALLOTHIONEIN 1, MOUSE; METALLOTHIONEIN-1, MOUSE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL IMMORTALIZATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DRUG POTENTIATION; GENE EXPRESSION REGULATION; HORMONE RESPONSIVE ELEMENT; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; REPORTER GENE; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TIME; TRANSCRIPTION REGULATION; ANIMAL; CELL TRANSFORMATION; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; KERATINOCYTE; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN TUMOR; WESTERN BLOTTING;

MUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CYTOPLASM; DESIPRAMINE; FLUOCINOLONE ACETONIDE; KERATINOCYTES; LUCIFERASES; METALLOTHIONEIN; MICE; PAPILLOMA; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 73349130773     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20564     Document Type: Article

References (33)

1. Tamim HM, Mahmud S, Hanley JA, Boivin JF, Stang MR, Collet JP. Antidepressants and risk of prostate cancer: A nested case-control study. Prostate Cancer Prostatic Dis 2008;11:53-60.
2. Sharpe CR, Collet JP, Belzile E, Hanley JA, Boivin JF. The effects of tricyclic antidepressants on breast cancer risk. Br J Cancer 2002;86:92-97.
3. Coogan PF. Review of the epidemiological literature on antidepressant use and breast cancer risk. Expert Rev Neurother 2006;6:1363-1374.
4. Chubak J, Buist DS, Boudreau DM, Rossing MA, Lumley T, Weiss NS. Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat 2007;112:123-132.
5. Xu W, Tamim H, Shapiro S, Stang MR, Collet JP. Use of antidepressants and risk of colorectal cancer: A nested case-control study. Lancet Oncol 2006;7:301-308.
6. Arimochi H, Morita K. Desipramine induces apoptotic cell death through nonmitochondrial and mitochondrial pathways in different types of human colon carcinoma cells. Pharmacology 2008;81:164-172.
7. Jan CR, Lu YC, Tseng LL, et al. Effect of the antidepressant desipramine on cytosolic Ca(2+) movement and proliferation in human osteosarcoma cells. Pharmacology 2003;69:190-196.
8. Qi H, Chen HZ, Jin ZJ. Caspase 3 gene expression and [Ca2+]i homeostasis underlying desipramine-induced C6 glioma cell apoptosis. Acta Pharmacol Sin 2002;23:803-807.
9. Arimochi H, Morita K. Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells. Eur J Pharmacol 2006;541:17-23.
10. Huang CJ, Cheng HH, Chou CT, et al. Desipramine-induced Ca2+ movement and cytotoxicity in PC3 human prostate cancer cells. Toxicol In Vitro 2007;21:449-456.
11. Budziszewska B, Jaworska-Feil L, Kajta M, Lason W. Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - A possible mechanism. Br J Pharmacol 2000;130:1385-1393.
12. Okugawa G, Omori K, Suzukawa J, Fujiseki Y, Kinoshita T, Inagaki C. Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones. J Neuroendocrinol 1999;11:887-895.
13. Herr AS, Tsolakidou AF, Yassouridis A, Holsboer F, Rein T. Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro. Neuroendocrinology 2003;78:12-22.
14. Pariante CM, Makoff A, Lovestone S, et al. Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br J Pharmacol 2001;134:1335-1343.
15. Pepin MC, Govindan MV, Barden N. Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Mol Pharmacol 1992;41:1016-1022.
16. Lai M, McCormick JA, Chapman KE, Kelly PA, Seckl JR, Yau JL. Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal culture. Neuroscience 2003;118:975-984.
17. Heiske A, Jesberg J, Krieg JC, Vedder H. Differential effects of antidepressants on glucocorticoid receptors in human primary blood cells and human monocytic U-937 cells. Neuropsychopharmacology 2003;28:807-817.
18. Okuyama-Tamura M, Mikuni M, Kojima I. Modulation of the human glucocorticoid receptor function by antidepressive compounds. Neurosci Lett 2003;34:206-210.
19. Pariante CM, Pearce BD, Pisell TL, Owens MJ, Miller AH. Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Mol Pharmacol 1997;52:571-581.
20. Funato H, Kobayashi A, Watanabe Y. Differential effects of antidepressants on dexamethasone-induced nuclear translocation and expression of glucocorticoid receptor. Brain Res 2006;1117:125-134.
21. Okret S, Dong Y, Tanaka H, Cairns B, Gustafsson JA. The mechanism for glucocorticoid-resistance in a rat hepatoma cell variant that contains functional glucocorticoid receptor. J Steroid Biochem Mol Biol 1991;40:353-361.
22. Langeveld CH, van Waas MP, Stoof JC, et al. Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone. J Neurosci Res 1992;31:524-531.
23. Moalli PA, Rosen ST. Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies. Leuk Lymphoma 1994;15:363-374.
24. Droms KA, Hanson LA, Malkinson AM, Beer DG. Altered dexamethasone responsiveness and loss of growth control in tumorigenic mouse lung cell lines. Int J Cancer 1993;53:1017-1022.
25. Budunova IV, Carbajal S, Kang H, Viaje A, Slaga TJ. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis. Mol Carcinog 1997;18:177-185.
26. Spiegelman VS, Budunova IV, Carbajal S, Slaga TJ. Resistance of transformed mouse keratinocytes to growth inhibition by glucocorticoids. Mol Carcinog 1997;20:99-107.
27. Karin M, Herschman HR. Glucocorticoid hormone receptor mediated induction of metallothionein synthesis in HeLa cells. J Cell Physiol 1980;103:35-40.
28. Klann RC, Fitzgerald DJ, Piccoli C, Slaga TJ, Yamasaki H. Gap-junctional intercellular communication in epidermal cell lines from selected stages of SENCAR mouse skin carcinogenesis. Cancer Res 1989;49:699-705.
29. Conti CJ, Fries JW, Viaje A, Miller DR, Morris R, Slaga T. In vivo behavior of murine epidermal cell lines derived from initiated and noninitiated skin. Cancer Res 1988;48:435-439.
30. Crouch SP, Kozlowski R, Slater KJ, Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods 1993;160:81-88.
31. Soriano AF, Helfrich B, Chan DC, Heasley LE, Bunn PA, Jr., Chou TC. Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines. Cancer Res 1999;59:6178-6184.
32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.
33. Ho CM, Kuo SY, Chen CH, Huang JK, Jan CR. Effect of desipramine on Ca2+ levels and growth in renal tubular cells. Cell Signal 2005;17:837-845.